Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.

Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients. J Am Heart Assoc. 2018 01 04; 7(1).

View in: PubMed

subject areas

Aged
Amlodipine
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Benzazepines
Blood Pressure
Calcium Channel Blockers
Cause of Death
Drug Therapy, Combination
Female
Humans
Hydrochlorothiazide
Hypertension
Male
Middle Aged
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Sodium Chloride Symporter Inhibitors
Time Factors
Treatment Outcome

authors with profiles

George Bakris